Investment
Features
FeesSafety
Academy
More
Pluang+

Emergent BioSolutions faces investigation after $191M asset impairment and 30% stock drop

Market News
17 Sep 2026
PRNewsWire
View Source
Bearish
Emergent BioSolutions faces investigation after $191M asset impairment and 30% stock drop

Emergent BioSolutions reported a $191.3 million non-cash impairment charge on its NARCAN asset group, resulting in a GAAP net loss of $180.2 million for the quarter ended June 30, 2026. The company also lowered its full-year revenue guidance by about 10.8%, citing increased competition affecting its outlook and asset value. Following this announcement, Emergent's stock price plunged nearly 30%. Pomerantz LLP has launched an investigation into whether Emergent and its executives engaged in securities fraud or other unlawful practices, potentially leading to a class action lawsuit.

Emergent BioSolutions is the subject of an investor alert regarding a legal investigation. For readers following the health sector, here is Pluang's market snapshot as of Sep 17, 2026 21:11 WIB: out of 91 priced US health stocks, 59 rose and 31 fell. Notable movers include RXRX at USD 3.37 with a 5.64% increase and 100% buy order activity, ILMN at USD 241.64 with a 5.55% rise and 97% sell order activity, and DNA at USD 7.44 with a 5.38% gain.

More News

Schrödinger stock dips 5% amid $55M Tectora co-founding and upcoming earnings forecast.

Schrödinger stock dips 5% amid $55M Tectora co-founding and upcoming earnings forecast.

Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...

Analyst Insights
Bullish
29 minutes ago
Johnson & Johnson beats Q3 earnings estimates, driven by strong pharmaceutical growth.

Johnson & Johnson beats Q3 earnings estimates, driven by strong pharmaceutical growth.

Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...

Company Fundamentals
Bullish
38 minutes ago
TSMC Q3 revenue beats forecasts as AI chip demand fuels strong growth.

TSMC Q3 revenue beats forecasts as AI chip demand fuels strong growth.

TSMC's preliminary Q3 2026 revenue reached approximately NT$1.49 trillion, about 50% higher year-over-year and above management guidance, driven by strong AI chip demand. The company holds a dominant 73% share of the global pure-play foundry market, ...

Company Fundamentals
Bullish
44 minutes ago
Inc. and SurveyMonkey launch Growth Signals to capture insights from fast-growing businesses.

Inc. and SurveyMonkey launch Growth Signals to capture insights from fast-growing businesses.

Inc. and SurveyMonkey have launched Growth Signals, a new initiative to regularly poll entrepreneurs and business leaders of fast-growing companies. This program aims to capture their priorities, challenges, and growth outlook to inform Inc.'s editor...

Others
Neutral
44 minutes ago
BNB Standard launches new website with real-time treasury dashboard to boost transparency and educate investors.

BNB Standard launches new website with real-time treasury dashboard to boost transparency and educate investors.

BNB Standard Corporation has launched a new corporate website featuring an expanded treasury dashboard that updates its Adjusted Net Asset Value and other key financial metrics intraday. This move aims to increase transparency and accountability in t...

Market News
Bullish
44 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App